Impact of procedural and patient-related risks on 1-year outcomes for patients treated with 1-month dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation

• DOI: 10.1007/s12928-025-01087-9
• Publication Date: 2025-01-17T00:39:00Z
• Authors: Ryutaro Shimada; Masaru Ishida; Fumiaki Takahashi; Masanobu Niiyama; Takenori Ishisone; Yuki Matsumoto; Yuya Taguchi; Takuya Osaki; Osamu Nishiyama; Hiroshi Endo; Ryohei Sakamoto; Kentaro Tanaka; Yorihiko Koeda; Takumi Kimura; Iwao Goto; Ryo Ninomiya; Wataru Sasaki; Kaho Shimada; Tomonori Itoh; Yoshihiro Morino